Response of cyclophosphamide-treated broiler chickens to challenge with velogenic Newcastle disease virus

This study investigated whether prior cyclophosphamide (CY) treatment influenced the susceptibility of young broiler chickens to velogenic Newcastle disease (vND) virus (vNDV) challenge. Broiler chickens treated with CY at 4 weeks of age showed a loss of weight, severe atrophy of the bursa and thymus and severe lymphocytic depletion in the bursa, spleen and thymus and lymphopaenia. On challenge at 6 weeks of age with vNDV, there were significant (p<.05) weight loss, severe depression, diarrhoea, coughing and sero-mucous nasal discharges and torticollis. Lesions included severe atrophy of the lymphoid organs and congested lungs. Proventricular, intestinal and caecal tonsil haemorrhages and ulcers were more severe in the CY-untreated than the treated broilers. Histopathology showed severe necrosis and depletion of the lymphocytes in the lymphoid organs, perivascular cuffin and endotheliosis in the brain. Total mortalities in the CY-treated and untreated broilers were 100% and 94.44%, respectively, by day 6 post-challenge. There was no statistical difference (p<.05) between the mortalities. These results show that CY treatment may not have an effect on the susceptibility of broilers to an acute disease like vND.